SIRT3 acts as delactylase to suppress hepatocellular carcinoma development

ABSTRACT: Our integrative studies characterized SIRT3 as a delactylase to suppress HCC development, and the activation of SIRT3 might be a promising therapeutic mean for HCC.

ORGANISM(S): Homo Sapiens

SUBMITTER: Yi Wang  

PROVIDER: PXD039202 | iProX | Tue Jan 03 00:00:00 GMT 2023

REPOSITORIES: iProX